Erythropoietin: A Candidate Neuroprotective Agent in the Treatment of Glaucoma
Authors:
- James C. TsaiJTJames C. Tsai
- Brian J. SongBSBrian J. Song
- Li WuLWLi Wu
- Max ForbesMFMax Forbes
- 1 September 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 16 (6) , 567-571
Abstract
Glaucoma is a progressive optic neuropathy that is the leading cause of irreversible blindness in the world. Although methods to lower intraocular pressure are the mainstay of glaucoma therapy, there are currently no available treatment modalities targeted at neuroprotection. Erythropoietin is a hematopoietic cytokine that has been shown to possess remarkable tissue-protective properties in preclinical models of neurodegeneration. As a result, there is a growing interest to explore the neuroprotective properties of erythropoietin as a possible therapeutic agent in neuropathic diseases of the eye such as glaucoma. Initial results in animal models have been promising, but further studies are needed to fully evaluate the safety and efficacy of this candidate neuroprotective agent in clinical trials.Keywords
This publication has 76 references indexed in Scilit:
- Erythropoietin Promotes Survival of Retinal Ganglion Cells in DBA/2J Glaucoma MiceInvestigative Ophthalmology & Visual Science, 2007
- Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promiseKidney International, 2006
- Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activitiesProceedings of the National Academy of Sciences, 2006
- Emerging biological roles for erythropoietin in the nervous systemNature Reviews Neuroscience, 2005
- Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivoKidney International, 2004
- Low-Dose Therapy With the Long-Acting Erythropoietin Analogue Darbepoetin Alpha Persistently Activates Endothelial Akt and Attenuates Progressive Organ FailureCirculation, 2004
- EPO and α-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidneyKidney International, 2004
- Erythropoietin protects against ischaemic acute renal injuryNephrology Dialysis Transplantation, 2004
- Hypoxia-Induced Stroke Tolerance in the Mouse Is Mediated by ErythropoietinStroke, 2003
- Preconditioning-mediated neuroprotection through erythropoietin?The Lancet, 2002